Inogen

Inogen EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Inogen (INGN) as of Oct 6, 2026 is -10.12 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -14.35 % — a change of -29.53% (higher).

EBIT/Assets

-10.12 %

YoY

-29.53%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Inogen is 2026 -10.12 % . Operating Income to Assets Ratio (EBIT/Assets) of Inogen was 2025 -14.35 % . It decreases by -29.53% higher compared to the previous year.

The Inogen EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
10.08 USD
Jan 1, 2019
4.42 USD
Jan 1, 2020
-2.60 USD
Jan 1, 2021
1.89 USD
Jan 1, 2022
-21.05 USD
Jan 1, 2023
-33.53 USD
Jan 1, 2024
-14.35 USD
Jan 1, 2025
-10.12 USD
The Inogen EBIT/Assets history
YEAREBIT/AssetsYoY
-10.12 %-29.53%
-14.35 %-57.19%
-33.53 %+59.34%
-21.05 %-1,214.94%
1.89 %-172.50%
-2.60 %-158.86%
4.42 %-56.12%
10.08 %+0.50%
10.03 %-6.10%
10.68 %+14.48%
9.33 %+24.35%
7.50 %—
Access this data via the Eulerpool API

Inogen Stock analysis

What does Inogen do? Inogen Inc. is an American company that specializes in the development and manufacturing of oxygen concentrators. The company was founded in 2001 and is headquartered in Goleta, California. Inogen has become a market leader in portable oxygen concentrators in the American market. The company offers high-quality products and services to improve the lives of patients with chronic lung problems. Inogen focuses on improving the quality of life by developing and manufacturing high-quality, durable, and reliable portable oxygen concentrators that integrate all necessary features for optimal mobility and freedom. It offers various products and services for patients, doctors, insurance companies, and community centers. Some of its products include the Inogen One G5, Inogen One G4, Inogen TAV, Inogen Carry Bag, and Inogen Battery. In summary, Inogen Inc. is a specialized company in the development and manufacturing of oxygen concentrators, with a focus on improving the lives of patients with chronic lung problems through high-quality portable solutions. Inogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inogen stock

Operating Income to Assets Ratio (EBIT/Assets) of Inogen is -10.12 % in 2026.

Operating Income to Assets Ratio (EBIT/Assets) of Inogen changed from -14.35 % to -10.12 %, representing a -29.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Inogen since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Inogen with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

Profitability — Inogen

All Key Metrics — Inogen